Search Results - "HORGAN, P. G"

Refine Results
  1. 1

    A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer by Proctor, M J, McMillan, D C, Morrison, D S, Fletcher, C D, Horgan, P G, Clarke, S J

    Published in British journal of cancer (07-08-2012)
    “…Background: The neutrophil lymphocyte ratio (NLR) has prognostic value in patients with a variety of cancers. Many chemotherapeutic trial databases hold…”
    Get full text
    Journal Article
  2. 2

    An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study by Proctor, M J, Morrison, D S, Talwar, D, Balmer, S M, O'Reilly, D S J, Foulis, A K, Horgan, P G, McMillan, D C

    Published in British journal of cancer (15-02-2011)
    “…Introduction: A selective combination of C-reactive protein and albumin (termed the modified Glasgow Prognostic Score, mGPS) has been shown to have prognostic…”
    Get full text
    Journal Article
  3. 3

    The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer by Park, J.H., Richards, C.H., McMillan, D.C., Horgan, P.G., Roxburgh, C.S.D.

    Published in Annals of oncology (01-03-2014)
    “…Tumour stroma percentage (TSP) has previously been reported to predict survival in patients with colorectal cancer (CRC); however, whether this is independent…”
    Get full text
    Journal Article
  4. 4

    Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer by Guthrie, G J K, Roxburgh, C S D, Farhan-Alanie, O M, Horgan, P G, McMillan, D C

    Published in British journal of cancer (09-07-2013)
    “…Background: The systemic inflammation-based prognostic scores, modified Glasgow Prognostic Score (mGPS) and the neutrophil-lymphocyte ratio (NLR) are now…”
    Get full text
    Journal Article
  5. 5

    The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study by Proctor, M J, Talwar, D, Balmar, S M, O'Reilly, D S J, Foulis, A K, Horgan, P G, Morrison, D S, McMillan, D C

    Published in British journal of cancer (07-09-2010)
    “…Background: Cancer incidence is increasing in the United Kingdom, as well as on a global basis. Biochemical parameters, such as C-reactive protein and albumin…”
    Get full text
    Journal Article
  6. 6

    Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer by Moyes, L H, Leitch, E F, McKee, R F, Anderson, J H, Horgan, P G, McMillan, D C

    Published in British journal of cancer (21-04-2009)
    “…The presence of systemic inflammation before surgery, as evidenced by the glasgow prognostic score (mGPS), predicts poor long-term survival in colorectal…”
    Get full text
    Journal Article
  7. 7

    Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer by LEITCH, E. F, CHAKRABARTI, M, CROZIER, J. E. M, MCKEE, R. F, ANDERSON, J. H, HORGAN, P. G, MCMILLAN, D. C

    Published in British journal of cancer (05-11-2007)
    “…There is increasing evidence that the presence of a systemic inflammatory response plays an important role in predicting survival in patients with colorectal…”
    Get full text
    Journal Article
  8. 8

    Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer by Guthrie, G J K, Roxburgh, C S D, Richards, C H, Horgan, P G, McMillan, D C

    Published in British journal of cancer (09-07-2013)
    “…Background: Cancer-associated inflammation, in the form of local and systemic inflammatory responses, appear to be linked to tumour necrosis and have…”
    Get full text
    Journal Article
  9. 9

    The Glasgow Microenvironment Score and risk and site of recurrence in TNM I–III colorectal cancer by Alexander, P. G., van Wyk, H. C., Pennel, K. A. F., Hay, J., McMillan, D. C., Horgan, P. G., Roxburgh, C. S. D., Edwards, J., Park, J. H.

    Published in British journal of cancer (16-02-2023)
    “…Background Glasgow Microenvironment Score (GMS) stratifies long-term survival into three groups based on tumour phenotype: peritumoural inflammation…”
    Get full text
    Journal Article
  10. 10

    The role of dietary polyphenols in the moderation of the inflammatory response in early stage colorectal cancer by Little, C. H., Combet, E., McMillan, D. C., Horgan, P. G., Roxburgh, C. S. D.

    “…Current focus in colorectal cancer (CRC) management is on reducing overall mortality by increasing the number of early-stage cancers diagnosed and treated with…”
    Get full text
    Journal Article
  11. 11

    The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer by Park, J.H, McMillan, D.C, Horgan, P.G, Roxburgh, C.S

    Published in Cancer treatment reviews (01-02-2014)
    “…Summary Although there is increasing appreciation of the role of the host inflammatory response in determining outcome in patients in colorectal cancer, there…”
    Get full text
    Journal Article
  12. 12

    Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer by Richards, C. H., Roxburgh, C. S. D., Anderson, J. H., McKee, R. F., Foulis, A. K., Horgan, P. G., McMillan, D. C.

    Published in British journal of surgery (01-02-2012)
    “…Background: Tumour necrosis is a marker of poor prognosis in some tumours but the mechanism is unclear. This study examined the prognostic value of tumour…”
    Get full text
    Journal Article
  13. 13

    Contribution of surgical specialization to improved colorectal cancer survival by Oliphant, R., Nicholson, G. A., Horgan, P. G., Molloy, R. G., McMillan, D. C., Morrison, D. S.

    Published in British journal of surgery (01-09-2013)
    “…Background Reorganization of colorectal cancer services has led to surgery being increasingly, but not exclusively, delivered by specialist surgeons. Outcomes…”
    Get full text
    Journal Article
  14. 14

    The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer by Richards, C H, Leitch, E F, Horgan, P G, Anderson, J H, McKee, R F, McMillan, D C

    Published in British journal of cancer (26-10-2010)
    “…Background: It is increasingly recognised that host-related factors may be important in determining cancer outcome. The aim was to examine the relationship…”
    Get full text
    Journal Article
  15. 15

    The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer by Richards, C H, Flegg, K M, SD Roxburgh, C, Going, J J, Mohammed, Z, Horgan, P G, McMillan, D C

    Published in British journal of cancer (05-06-2012)
    “…Background: The host inflammatory response is an important determinant of cancer outcome. We examined different methods of assessing the local inflammatory…”
    Get full text
    Journal Article
  16. 16

    Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients by Willder, J M, Heng, S J, McCall, P, Adams, C E, Tannahill, C, Fyffe, G, Seywright, M, Horgan, P G, Leung, H Y, Underwood, M A, Edwards, J

    Published in British journal of cancer (15-01-2013)
    “…Background: Prostate cancer cell growth is dependent upon androgen receptor (AR) activation, which is regulated by specific kinases. The aim of the current…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme by Mansouri, D, McMillan, D C, Roxburgh, C S D, Crighton, E M, Horgan, P G

    Published in British journal of cancer (09-07-2013)
    “…Background: There is increasing evidence that aspirin, statins and ACE-inhibitors can reduce the incidence of colorectal cancer. The aim of the present study…”
    Get full text
    Journal Article
  20. 20